- Corporate Officers - N
- Nea 13 Gp, Ltd
Insider Trading History of Nea 13 Gp, Ltd
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nea 13 Gp, Ltd since 2012.
This trader's CIK number is 1460751.
At the time of last reporting, Nea 13 Gp, Ltd was the 10% Owner of Sagimet Biosciences Inc.. (stock ticker symbol SGMT).
Also see all insider trading activities at Sagimet Biosciences Inc..
Note that in the past
NEA 13 GP, Ltd also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Omthera Pharmaceuticals, Inc. (OMTH) by Nea 13 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | OMTH | 625,000 | $5,000,000 | 196 | $1,568 | 0 | $0 |
Yearly summary of insider trading at Ra Pharmaceuticals, Inc. (RARX) by Nea 13 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | RARX | 338,462 | $4,400,006 | 435 | $5,655 | 0 | $0 |
Yearly summary of insider trading at Rhythm Pharmaceuticals, Inc. (RYTM) by Nea 13 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | RYTM | 550,000 | $9,350,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tesaro, Inc. (TSRO) by Nea 13 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | TSRO | 116,445 | $6,710,700 | 0 | $0 | 0 | $0 |
2016 | TSRO | 710,429 | $24,999,996 | 0 | $0 | 0 | $0 |
2012 | TSRO | 1,111,111 | $14,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Nea 13 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | EPZM | 1,111,111 | $9,999,999 | 0 | $0 | 0 | $0 |
2013 | EPZM | 806,500 | $14,113,356 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Roka Bioscience, Inc. (ROKA) by Nea 13 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | ROKA | 383,333 | $4,599,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Millennial Media Inc. (MM) by Nea 13 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | MM | 0 | $0 | 1,597,787 | $21,479,050 | 0 | $0 |
Yearly summary of insider trading at Cvent Inc (CVT) by Nea 13 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | CVT | 0 | $0 | 1,302,476 | $46,237,897 | 0 | $0 |
Yearly summary of insider trading at Sagimet Biosciences Inc. (SGMT) by Nea 13 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | SGMT | 30,000 | $480,000 | 662 | $10,592 | 0 | $0 |
Insider trading activities at 9 companies by Nea 13 Gp, Ltd:
1. Omthera Pharmaceuticals, Inc. (OMTH)
2. Ra Pharmaceuticals, Inc. (RARX)
3. Rhythm Pharmaceuticals, Inc. (RYTM)
4. Tesaro, Inc. (TSRO)
5. Epizyme, Inc. (EPZM)
6. Roka Bioscience, Inc. (ROKA)
7. Millennial Media Inc. (MM)
8. Cvent Inc (CVT)
9. Sagimet Biosciences Inc. (SGMT)
Table 1. Insider trading of Omthera Pharmaceuticals, Inc. (OMTH) by Nea 13 Gp, Ltd
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-04-16 | OMTH | Buy | 625,000 | 8.00 | 5,000,000 |
2013-04-16 | OMTH | Sale | 196 | 8.00 | 1,568 |
Table 2. Insider trading of Ra Pharmaceuticals, Inc. (RARX) by Nea 13 Gp, Ltd
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-10-31 | RARX | Buy | 338,462 | 13.00 | 4,400,006 |
2016-10-31 | RARX | Sale | 435 | 13.00 | 5,655 |
Table 3. Insider trading of Rhythm Pharmaceuticals, Inc. (RYTM) by Nea 13 Gp, Ltd
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-10-10 | RYTM | Buy | 550,000 | 17.00 | 9,350,000 |
Table 4. Insider trading of Tesaro, Inc. (TSRO) by Nea 13 Gp, Ltd
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-03-02 | TSRO | Buy | 54,642 | 55.83 | 3,050,881 |
2018-03-05 | TSRO | Buy | 49,169 | 59.06 | 2,904,117 |
2018-03-06 | TSRO | Buy | 12,634 | 59.81 | 755,702 |
2016-03-18 | TSRO | Buy | 710,429 | 35.19 | 24,999,996 |
2012-07-03 | TSRO | Buy | 1,111,111 | 13.50 | 14,999,998 |
Table 5. Insider trading of Epizyme, Inc. (EPZM) by Nea 13 Gp, Ltd
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-01-12 | EPZM | Buy | 1,111,111 | 9.00 | 9,999,999 |
2013-11-14 | EPZM | Buy | 357,000 | 19.98 | 7,132,860 |
2013-11-15 | EPZM | Buy | 49,500 | 19.81 | 980,496 |
2013-06-05 | EPZM | Buy | 400,000 | 15.00 | 6,000,000 |
Table 6. Insider trading of Roka Bioscience, Inc. (ROKA) by Nea 13 Gp, Ltd
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-07-22 | ROKA | Buy | 383,333 | 12.00 | 4,599,996 |
Table 7. Insider trading of Millennial Media Inc. (MM) by Nea 13 Gp, Ltd
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-10-29 | MM | Sale | 1,597,787 | 13.44 | 21,479,050 |
Table 8. Insider trading of Cvent Inc (CVT) by Nea 13 Gp, Ltd
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-01-21 | CVT | Sale | 169,887 | 35.50 | 6,030,988 |
2014-01-16 | CVT | Sale | 1,132,589 | 35.50 | 40,206,909 |
Table 9. Insider trading of Sagimet Biosciences Inc. (SGMT) by Nea 13 Gp, Ltd
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-07-18 | SGMT | Buy | 30,000 | 16.00 | 480,000 |
2023-07-18 | SGMT | Sale | 662 | 16.00 | 10,592 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Nea 13 Gp, Ltd
(10% Owner of Sagimet Biosciences Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.